Comparison

DR6 Antibody

Item no. PRS-2157-0.02mg
Manufacturer ProSci
Amount 0.02 mg
Category
Type Antibody Polyclonal
Format Liquid
Applications WB, ELISA
Specific against Human
Host Rabbit
ECLASS 10.1 32160702
ECLASS 11.0 32160702
UNSPSC 12352203
Alias DR6 Antibody: DR6, CD358, BM-018, DR6, UNQ437/PRO868, Tumor necrosis factor receptor superfamily member 21, Death receptor 6
Available
Shipping
blue ice or RT
By Research Area
Apoptosis
Homology
Predicted species reactivity based on immunogen sequence: Rat: (73%), Mouse: (73%)
Immunogen
DR6 antibody was raised against a 15 amino acid peptide near the amino terminus of human DR6.

The immunogen is located within amino acids 30 - 80 of DR6.
Applications
DR6 antibody can be used for detection of DR6 by Western blot at 1:500 dilution. An approximately 68 kDa band can be detected.

Antibody validated: Western Blot in human samples. All other applications and species not yet tested.
Positive Control 1
Cat. No. 1201 - HeLa Cell Lysate
Positive Control 2
Cat. No. 1204 - K562 Cell Lysate
Predicted Molecular Weight
68 kDa
Purification
DR6 Antibody is Antibody is DEAE purified.
Clonality
Polyclonal
Isotype
IgG
Conjugate
Unconjugated
Buffer
DR6 Antibody is supplied in PBS containing 0.02% sodium azide.
Concentration
1 mg/ml
Storage Conditions
DR6 antibody can be stored at 4˚ C for three months and -20˚ C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Related Products
Cat. No. 2157P – DR6 Peptide
Disclaimer
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
Modifications
None
Ncbi Official Symbol
TNFRSF21
Accession #
AF068868
Protein Gi #
3549262
Ncbi Gene Id #
27242
User Note
Optimal dilutions for each application to be determined by the researcher.
Ncbi Official Symbol
TNFRSF21
Ncbi Official Full Name
tumor necrosis factor receptor superfamily, member 21
Ncbi Organism
Homo sapiens
Swissprot #
O75509
Background
DR6 Antibody: Apoptosis is induced by certain cytokines including TNF and Fas ligand of the TNF family through their death domain containing receptors, TNF-R1 and Fas. Several novel death receptors including DR3, DR4, and DR5 were recently identified. A new death domain containing receptor in the TNFR family was cloned recently and termed DR6 for death receptor-6. Like TNF-R1, DR6 interacts with death domain containing adapter molecule TRADD. Overexpression of DR6 induces apoptosis and activates NF-κ B and JNK. DR6 is widely expressed in human tissues and cell lines. The ligand for DR6 has not been identified.
Background References 1
Pan G, Bauer JH, Haridas V, Wang S, Liu D, Yu G, Vincenz C, Aggarwal BB, Ni J, Dixit VM. Identification and functional characterization of DR6, a novel death domain-containing TNF receptor. FEBS Lett 1998; 431:351-6
1st Image Caption
Western blot analysis of DR6 in K562 (1, 3) and Raji (2, 4) whole cell lysate in the absence (1, 2) or presence (3, 4) of blocking peptide (Catalog no. 2157P) with DR6 antibody at 1:500 dilution.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 0.02 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close